Author | Sattva Neelapu, MD | OncLive

Author | Sattva Neelapu, MD

Articles

Dr. Neelapu on the Safety Profile of ALLO-501 Plus ALLO-647 in R/R B-Cell Lymphomas

June 29, 2020

Video

Sattva Neelapu, MD, discusses the safety profile of ALLO-501 in combination with ALLO-647 in patients with relapsed/refractory large B-cell lymphoma or follicular lymphoma.

Dr. Neelapu on ALLO-501 Plus ALLO-647 in Relapsed/Refractory B-Cell Lymphomas

June 09, 2020

Video

Sattva Neelapu, MD, discusses the mechanism of action of ALLO-501 when paired with ALLO-647 in patients with relapsed/refractory large B-cell lymphoma or follicular lymphoma.

Dr. Neelapu on ALLO-501 Plus ALLO-647 in Relapsed/Refractory B-Cell Lymphomas

June 08, 2020

Video

Sattva Neelapu, MD, discusses the mechanism of action of ALLO-501 when paired with ALLO-647 in patients with relapsed/refractory large B-cell lymphoma or follicular lymphoma.

Dr. Neelapu on Third-Line CAR T-Cell Therapy in Large B-Cell Lymphoma

July 31, 2019

Video

Sattva Neelapu, MD, discusses the use of CAR T-cell therapy in the third-line setting for patients with large B-cell lymphoma.

x